Bunion Market

1. Bunion Market A Bunion, known technically as hallux valgus, is a bony bump on the side of the foot at the base of the big toe. Bunions develop slowly as pressure on the joint at the base of the big toe causes the toe to move out of place, leaning inward toward the second toe. It is a progressive foot deformity in which the first metatarsophalangeal (MTP) joint is affected and is often accompanied by significant functional disability and foot pain. At a late stage, these changes lead to pain and functional deficit: i.e. impaired gait (lateral and posterior weight shift, late heel rise, decreased single-limb balance, and pronation deformity). DelveInsight's "Bunion Market Insights, 2030" report delivers an in-depth understanding of the Bunion, historical and forecasted epidemiology as well as the Bunion market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Epidemiology, and Market Forecast- The Bunion market report provides current treatment practices, emerging drugs, Bunion market share of the individual therapies, current and forecasted Bunion market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Bunion treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. Geography Covered: The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. Study Period: 2017-2030 View full report: https://www.delveinsight.com/report-store/bunion-market Bunion Disease Understanding and Treatment Algorithm

2. Bunions may be hereditary, as they often run in families. This suggests that people may inherit a faulty foot shape. In addition, footwear that does not fit properly may cause bunions. Bunions are made worse by shoes that are tight, fit poorly, or are too small. Bunions may also be caused by inflammatory conditions such as arthritis. Many people do not experience symptoms in the early stages of bunion formation. Symptoms are often most noticeable when the bunion gets worse and with certain types of footwear. These include shoes that crowd the toes and/or high-heeled shoes. When symptoms do occur, they may include: physical discomfort or pain, a burning feeling, redness, swelling, possible numbness and difficulty in walking. Factors responsible for the development of hallux valgus include, gender (10 times more frequent in women), footwear (tight pointed shoes), congenital deformity or predisposition chronic achilles tightness, severe flatfoot and hypermobility of the first metatarsocunie form joint systemic disease. Wearing tight shoes and/or heeled shoes between 20 and 39 years of age can be crucial in the development of hallux valgus in later years. The DelveInsight Bunion market report gives a thorough understanding of the Bunion by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. Request for sample pages: https://www.delveinsight.com/sample-request/bunion- market Bunion Epidemiology As per a study titled “Epidemiology and impact of hallux valgus: more than just bunions”, the estimated prevalence of Hallux Valgus was found to be 23% in adults aged 18 to 65 years. Also, it has been suggested that the association between Hallux Valgus and BMI differs between the genders, with a lower prevalence with increasing BMI in women but no association in men. The Bunion epidemiology division provide insights about historical and current Bunion patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken. Download epidemiology insights of the report: https://www.delveinsight.com/report- store/hallux-valgus-epidemiology-forecast Key Findings  The National health surveys in the United States have reported a prevalence of 0.9% across all age groups, while another survey in the United Kingdom reported a prevalence of 28.4% in adults. Research conducted in elderly populations has indicated prevalence rates as high as 74%. Individual studies have reported that Hallux Valgus is more common in female and elderly individuals than in males.

3. The disease epidemiology covered in the report provides historical as well as forecasted Bunion epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030. Bunion Drug Chapters The dynamics of Hallux Valgus (Bunion) market is anticipated to change in the coming years owing to the improvement in the research and development undertaking. The dynamics of treatment for Hallux Valgus depends majorly on surgical procedures as they provide better and long-term relief to the patients. Several pain relief medications are being developed for post-surgical bunionectomy pain relief. The pipeline for Hallux Valgus (Bunion) is not very robust with companies like Concentric Analgesics (CA-008), Taiwan Liposome Company (TLC590) Pacira Pharmaceuticals (SKY0402, Liposome bupivacaine), Pfizer (Valdecoxib) and others being the key players for pain relief. Drug chapter segment of the Bunion report encloses the detailed analysis of Bunion marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Bunion clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases. Click here and download pipeline @https://www.delveinsight.com/report-store/hallux-valgus-pipeline-insight Bunion Market Outlook Currently, the treatment paradigm for Hallux Valgus (Bunion) is still under clinical trials phase and there are no approved therapies for the indication. However, various other treatment options available for Bunion includes non-surgical treatments, surgical treatments management by physiotherapy. There are many operative techniques for hallux valgus correction. The decision on which surgical technique is used depends on the degree of deformity, the extent of degenerative changes of the first metatarsophalangeal joint and the shape and size of the metatarsal bone and phalangeal deviation. Recently, minimally invasive percutaneous techniques have gained importance and are currently being evaluated more scientifically. The Bunion market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Bunion market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment gives a thorough detail of Bunion market trend of each marketed drug and late- stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. insights of the report

4. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, Bunion market in 7MM is expected to change in the study period 2017-2030. Download our report @https://www.delveinsight.com/report-store/bunion-market Download free sample pages of the report: https://www.delveinsight.com/sample- request/bunion-market Related Report:    Hallux Valgus Market Insights, Epidemiology, and Market Forecast-2030 Hallux Valgus (Bunion) Epidemiology Forecast to 2030 Hallux Valgus Pipeline Insight, 2020